Threonine

Threonine

SCHEMBL7587312

CC(O)C(N)C(=O)O.c1ccc(COCc2ccccc2)cc1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A1 P43005 4/20 0.57
SLC1A3 P43003 3/20 0.57
SLC1A2 P43004 3/20 0.57
MEN1 O00255 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
KMT2A Q03164 1/20 0.57
TSHR P16473 2/20 0.50
ALOX5 P09917 2/20 0.49
SLC15A1 P46059 1/20 0.48
XIAP P98170 2/20 0.46
ALDH1A1 P00352 2/20 0.44
ALPI P09923 1/20 0.44
PKM P14618 1/20 0.44
PTGS1 P23219 1/20 0.44
SLC7A5 Q01650 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Threonine SCHEMBL7587327 1.00 SLC1A1 (0.57) SLC1A1SLC1A3SLC1A2MEN1CYP1A2
Valine SCHEMBL9779769 0.88 SLC1A1 (0.58) SLC1A1SLC1A3SLC1A2MEN1CYP1A2
Threonine SCHEMBL29102361 0.83 SLC1A3 (0.50) SLC1A1SLC1A3SLC1A2MEN1CYP1A2
SCHEMBL724210 0.82 SLC1A1 (0.57) SLC1A1SLC1A3SLC1A2MEN1CYP1A2
SCHEMBL8232952 0.81 ALDH1A1 (0.55) SLC1A1SLC1A3SLC1A2MEN1CYP1A2
SCHEMBL17878731 0.81 ALDH1A1 (0.55) SLC1A1SLC1A3SLC1A2MEN1CYP1A2
SCHEMBL14908325 0.81 ALDH1A1 (0.55) SLC1A1SLC1A3SLC1A2MEN1CYP1A2
SCHEMBL216743 0.81 ALDH1A1 (0.55) SLC1A1SLC1A3SLC1A2MEN1CYP1A2
SCHEMBL12053128 0.81 ALDH1A1 (0.55) SLC1A1SLC1A3SLC1A2MEN1CYP1A2
SCHEMBL216744 0.81 ALDH1A1 (0.55) SLC1A1SLC1A3SLC1A2MEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4363436-A1 CASPASE-2 INHIBITOR COMPOUNDS Kintsugi Therapeutics S.L. (ES) 2024-05-08 EP claimed
CN-117940444-A Caspase-2 inhibitor compounds 金特速吉医疗有限责任公司 2024-04-26 CN claimed
WO-2023275357-A1 CASPASE-2 INHIBITOR COMPOUNDS Kintsugi Therapeutics S.L. (ES) 2023-01-05 WO claimed
EP-4112631-A1 CASPASE-2 INHIBITOR COMPOUNDS Kintsugi Therapeutics S.L. (ES) 2023-01-04 EP claimed
EP-4363436-A1 CASPASE-2 INHIBITOR COMPOUNDS Kintsugi Therapeutics S.L. (ES) 2024-05-08 EP disclosed
CN-117940444-A Caspase-2 inhibitor compounds 金特速吉医疗有限责任公司 2024-04-26 CN disclosed
WO-2023275357-A1 CASPASE-2 INHIBITOR COMPOUNDS Kintsugi Therapeutics S.L. (ES) 2023-01-05 WO disclosed
EP-4112631-A1 CASPASE-2 INHIBITOR COMPOUNDS Kintsugi Therapeutics S.L. (ES) 2023-01-04 EP disclosed
WO-2002100885-A2 A PENTA- OR TETRAPEPTIDE BINDING TO SOMATOSTATIN RECEPTORS AND THE USE OF THE SAME NOVASPIN BIOTECH GMBH (DE) 2002-12-19 WO disclosed